These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 19052510)

  • 1. [Clinical pathway for management of patients with acute asthma attack].
    Azuma N; Katada Y; Kobayashi M; Kojima M; Nakajima Y; Shibano M; Tomita H; Yamanaka T; Harada Y; Ishii T; Saeki Y
    Arerugi; 2008 Nov; 57(11):1155-65. PubMed ID: 19052510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of intravenous terbutaline versus normal saline in pediatric patients on continuous high-dose nebulized albuterol for status asthmaticus.
    Bogie AL; Towne D; Luckett PM; Abramo TJ; Wiebe RA
    Pediatr Emerg Care; 2007 Jun; 23(6):355-61. PubMed ID: 17572517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study.
    Donohue JF; Hanania NA; Ciubotaru RL; Noe L; Pasta DJ; Schaefer K; Claus R; Andrews WT; Roach J
    Clin Ther; 2008; 30 Spec No():989-1002. PubMed ID: 18640474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of nebulized fluticasone propionate in adult patients admitted to the emergency department due to bronchial asthma attack.
    Starobin D; Bolotinsky L; Or J; Fink G; Shtoeger Z
    Isr Med Assoc J; 2008; 10(8-9):568-71. PubMed ID: 18847151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ipratropium bromide plus nebulized albuterol for the treatment of hospitalized children with acute asthma.
    Craven D; Kercsmar CM; Myers TR; O'riordan MA; Golonka G; Moore S
    J Pediatr; 2001 Jan; 138(1):51-58. PubMed ID: 11148512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized controlled trial of intravenous magnesium sulphate as an adjunct to standard therapy in acute severe asthma.
    Singh AK; Gaur S; Kumar R
    Iran J Allergy Asthma Immunol; 2008 Dec; 7(4):221-9. PubMed ID: 19052352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
    Murphy K; Noonan M; Silkoff PE; Uryniak T
    Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective evaluation of the 1-hour decision point for admission versus discharge in acute asthma.
    Wilson MM; Irwin RS; Connolly AE; Linden C; Manno MM
    J Intensive Care Med; 2003; 18(5):275-85. PubMed ID: 15035763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of inhaled versus systemic corticosteroids on exhaled nitric oxide in severe acute asthma.
    Khoo SM; Lim TK
    Respir Med; 2009 Apr; 103(4):614-20. PubMed ID: 19022641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early intervention with inhaled corticosteroids in subjects with rapid decline in lung function and signs of bronchial hyperresponsiveness: results from the DIMCA programme.
    den Otter JJ; van Schayck CP; Folgering HT; van den Boom G; Akkermans RP; van Weel C
    Eur J Gen Pract; 2007; 13(2):89-91. PubMed ID: 17534745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ipratropium for acute asthma in adults.
    Holten KB
    Can Fam Physician; 2000 Dec; 46():2406-7. PubMed ID: 11153407
    [No Abstract]   [Full Text] [Related]  

  • 12. Effectiveness of a clinical pathway for inpatient asthma management.
    Johnson KB; Blaisdell CJ; Walker A; Eggleston P
    Pediatrics; 2000 Nov; 106(5):1006-12. PubMed ID: 11061767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exhaled nitric oxide for monitoring childhood asthma inflammation compared to sputum analysis, serum interleukins and pulmonary function.
    Paro-Heitor ML; Bussamra MH; Saraiva-Romanholo BM; Martins MA; Okay TS; Rodrigues JC
    Pediatr Pulmonol; 2008 Feb; 43(2):134-41. PubMed ID: 18085692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of disease duration on dose-response of inhaled budesonide in asthma.
    Selroos O
    Respir Med; 2008 Jul; 102(7):1065-72. PubMed ID: 18387797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of acute asthma.
    Murphy S; Kelly HW
    Pediatrician; 1991; 18(4):287-300. PubMed ID: 1796016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Status asthmaticus, severe acute asthma or severe exacerbation of asthma.
    Picado C
    Allergol Immunopathol (Madr); 1985; 13(5):435-7. PubMed ID: 4083236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The beneficial effects of Xolair (omalizumab) as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available treatment (GINA 2002 step IV)--the Israeli arm of the INNOVATE study.
    Sthoeger ZM; Eliraz A; Asher I; Berkman N; Elbirt D
    Isr Med Assoc J; 2007 Jun; 9(6):472-5. PubMed ID: 17642399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do current treatment protocols adequately prevent airway remodeling in children with mild intermittent asthma?
    Bibi HS; Feigenbaum D; Hessen M; Shoseyov D
    Respir Med; 2006 Mar; 100(3):458-62. PubMed ID: 16046260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE.
    Humbert M; Beasley R; Ayres J; Slavin R; Hébert J; Bousquet J; Beeh KM; Ramos S; Canonica GW; Hedgecock S; Fox H; Blogg M; Surrey K
    Allergy; 2005 Mar; 60(3):309-16. PubMed ID: 15679715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early administration of two intravenous bolus of aminophylline added to the standard treatment of children with acute asthma.
    D'Avila RS; Piva JP; Marostica PJ; Amantea SL
    Respir Med; 2008 Jan; 102(1):156-61. PubMed ID: 17869497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.